iTeos Therapeutics Inc.

NASDAQ: ITOS · Real-Time Price · USD
7.58
-0.27 (-3.44%)
At close: May 14, 2025, 3:59 PM
7.70
1.52%
Pre-market: May 15, 2025, 08:04 AM EDT

iTeos Therapeutics Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
License and Service Revenue 35M 12.6M 267.6M
License and Service Revenue Growth +177.78% -95.29% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selling, General, and Administrative Revenue 10.98M 11.81M 12.11M 12.46M 12.7M 12.37M 12.64M 13.44M 11.93M 11.1M 10.76M 11.47M 10.62M 9.6M 8.76M 15.1M 7.05M 5.73M 4.8M 2.39M 2.42M 2.28M 2.7M 2.09M 1.77M
Selling, General, and Administrative Revenue Growth -7.00% -2.50% -2.77% -1.94% +2.71% -2.16% -5.90% +12.64% +7.44% +3.17% -6.20% +8.06% +10.60% +9.55% -41.98% +114.32% +22.99% +19.38% +100.46% -0.99% +6.24% -15.67% +28.95% +18.32% n/a
Research and Development Revenue 29.04M 37.52M 36.69M 36.4M 34.23M 27.78M 30.64M 29.19M 25.6M 25.42M 23.93M 26.91M 21.1M 17.39M 16.1M 14.24M 11.64M 9.21M 8.73M 6.14M 5.83M 5.96M 5M 3.9M 4.35M
Research and Development Revenue Growth -22.61% +2.28% +0.79% +6.36% +23.21% -9.34% +4.97% +14.02% +0.70% +6.22% -11.07% +27.56% +21.34% +7.97% +13.09% +22.29% +26.39% +5.57% +42.19% +5.36% -2.27% +19.25% +28.09% -10.32% n/a